Phase II monotherapy efficacy of cancer metabolism targeting SM-88 in heavily pre-treated PDAC patients

Category Primary study
ConferenceAnnals of Oncology
Year 2019
This article has no abstract
Epistemonikos ID: 634f841c87a16e9c0fc95da6622ed69e93e10ff8
First added on: Feb 11, 2025